Correlation between serum markers and transjugular intrahepatic portosystemic shunt prognosis in patients with cirrhotic ascites

被引:0
作者
Hu, Xiao-Gang [1 ]
Yang, Xiao-Xian [2 ]
Lu, Jun [1 ]
Li, Gang [1 ]
Dai, Jian-Ji [1 ]
Wang, Jia-Min [1 ]
Deng, Yi [1 ]
Feng, Rui [3 ,4 ]
机构
[1] Zhejiang Univ, Affiliated Jinhua Hosp, Dept Intervent Radiol, Sch Med, Jinhua 321000, Zhejiang, Peoples R China
[2] Jinhua Polytech, Med Coll, Jinhua 321017, Zhejiang, Peoples R China
[3] Hangzhou Med Coll, Zhejiang Prov Peoples Hosp, Dept Intervent Med, Peoples Hosp, Hangzhou 310000, Zhejiang, Peoples R China
[4] Hangzhou Med Coll, Zhejiang Prov Peoples Hosp, Dept Intervent Med, Peoples Hosp, 158 Shangtang Rd, Hangzhou 310000, Zhejiang, Peoples R China
来源
WORLD JOURNAL OF GASTROINTESTINAL SURGERY | 2024年 / 16卷 / 02期
关键词
Liver cirrhosis; Refractory ascites; Transjugular intrahepatic portosystemic shunt; Cystatin C; INTERNATIONAL NORMALIZED RATIO; CYSTATIN-C; RENAL-FUNCTION; MANAGEMENT; BIOMARKER;
D O I
10.4240/wjgs.v16.i2.481
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND Individuals with refractory ascites in the context of liver cirrhosis typically face an adverse prognosis. The transjugular intrahepatic portosystemic shunt (TIPS) is an efficacious intervention, but there is a lack of reliable tools for postoperative prognosis assessment. Previously utilized clinical biochemical markers, such as the serum albumin concentration (Alb), sodium (Na+) concentration, and serum creatinine (Scr), have limited predictive value. Therefore, the quest for novel, specific biomarkers to evaluate the post-TIPS prognosis in patients with liver cirrhosis and refractory ascites holds significant practical importance. AIM To investigate the associations between the Child-Pugh score, model for end-stage liver disease (MELD) score, and serum cystatin C (Cys C) level and post-TIPS prognosis in patients with liver cirrhosis and refractory ascites. METHODS A retrospective analysis was conducted on 75 patients with liver cirrhosis and refractory ascites who underwent TIPS at our institution from August 2019 to August 2021. These patients were followed up regularly for two years, and the death toll was meticulously documented. The patients were allocated into a survival group (n = 45 patients) or a deceased group (n = 30 patients) based on their prognosis status. The clinical data of the two groups were collected, and Child-Pugh scores and MELD scores were calculated for analysis. Spearman correlation analysis was carried out to evaluate the correlation of prognosis with Child-Pugh grade, MELD score, and Cys C level. Additionally, a multiple-factor analysis utilizing the Cox proportional hazard model was used to identify independent risk factors affecting the post-TIPS prognosis of patients with liver cirrhosis and refractory ascites. The receiver operating characteristic curve (ROC) ascertained the predictive value of the Cys C concentration, Child-Pugh grade, and MELD score for the prognosis of liver cirrhosis with refractory ascites in post-TIPS patients. RESULTS During a 2-year follow-up period, among 75 patients with liver cirrhosis and refractory ascites who underwent TIPS treatment, 30 patients (40.00%) passed away. The deceased cohort exhibited heightened aspartate aminotransferase, alanine aminotransferase, total bilirubin, Scr, prothrombin time, Cys C, international normalized ratio, Child-Pugh, and MELD scores compared to those of the survival cohort, while Alb and Na+ levels were attenuated in the deceased group (P < 0.05). Spearman analysis revealed moderate to high positive correlations between prognosis and Child-Pugh score, MELD score, and Cys C level (r = 0.709, 0.749, 0.671, P < 0.05). Multivariate analysis using the Cox proportional hazard model demonstrated that the independent risk factors for post-TIPS prognosis in patients with liver cirrhosis and refractory ascites were Cys C (HR = 3.802; 95%CI: 1.313-11.015), Child-Pugh (HR = 3.030; 95%CI: 1.858-4.943), and MELD (HR = 1.222; 95%CI: 1.073-1.393) scores. ROC analysis confirmed that, compared to those of the classic prognostic models for Child-Pugh and MELD scores, the predictive accuracy of Cys C for post-TIPS prognosis in patients with liver cirrhosis and refractory ascites was slightly lower. This analysis yielded sensitivity and specificity values of 83.33% and 82.22%, respectively. The area under the curve value at this juncture was 0.883, with an optimal cutoff value set at 1.95 mg/L. CONCLUSION Monitoring the serum Cys C concentration is valuable for assessing the post-TIPS prognosis in patients with liver cirrhosis and refractory ascites. Predictive models based on serum Cys C levels, as opposed to Scr levels, are more beneficial for evaluating the condition and prognosis of patients with ascites due to cirrhosis.
引用
收藏
页数:11
相关论文
共 34 条
  • [1] Refractory Ascites in Liver Cirrhosis
    Adebayo, Danielle
    Neong, Shuet Fong
    Wong, Florence
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 (01) : 40 - 47
  • [2] Guidelines on the management of ascites in cirrhosis
    Aithal, Guruprasad P.
    Palaniyappa, Naaventhan
    China, Louise
    Harmala, Suvi
    Macken, Lucia
    Ryan, Jennifer M.
    Wilkes, Emilie A.
    Moore, Kevin
    Leithead, Joanna A.
    Hayes, Peter C.
    O'Brien, Alastair J.
    Verma, Sumita
    [J]. GUT, 2021, 70 (01) : 9 - 29
  • [3] The first Chinese guidelines on the Management of Ascites and its Related Complications in Cirrhosis: a great goal for a great country
    Angeli, P.
    [J]. HEPATOLOGY INTERNATIONAL, 2019, 13 (04) : 395 - 398
  • [4] The Evolving Challenge of Infections in Cirrhosis
    Bajaj, Jasmohan S.
    Kamath, Patrick S.
    Reddy, K. Rajender
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (24) : 2317 - 2330
  • [5] Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event
    Balcar, Lorenz
    Tonon, Marta
    Semmler, Georg
    Calvino, Valeria
    Hartl, Lukas
    Incicco, Simone
    Jachs, Mathias
    Bauer, David
    Hofer, Benedikt Silvester
    Gambino, Carmine Gabriele
    Accetta, Antonio
    Brocca, Alessandra
    Trauner, Michael
    Mandorfer, Mattias
    Piano, Salvatore
    Reiberger, Thomas
    Baveno Cooperation EASL consortium
    [J]. JHEP REPORTS, 2022, 4 (08)
  • [6] Updates on the Model for End-Stage Liver Disease Score and Impact on the Liver Transplant Waiting List: A Narrative Review
    Bayona Molano, Maria del Pilar
    Gutierrez, Juan Carlos Barrera
    Landinez, Gina
    Mejia, Alejandro
    Haskal, Ziv J.
    [J]. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2023, 34 (03) : 337 - 343
  • [7] Favaloro EJ, 2017, METHODS MOL BIOL, V1646, P59, DOI 10.1007/978-1-4939-7196-1_4
  • [8] Evaluation of serum cystatin C concentration as a marker of renal function in patients with cirrhosis of the liver
    Gerbes, AL
    Gülberg, V
    Bilzer, M
    Vogeser, M
    [J]. GUT, 2002, 50 (01) : 106 - 110
  • [9] Liver cirrhosis
    Gines, Pere
    Krag, Aleksander
    Abraldes, Juan G.
    Sola, Elsa
    Fabrellas, Nuria
    Kamath, Patrick S.
    [J]. LANCET, 2021, 398 (10308) : 1359 - 1376
  • [10] THE INTERNATIONAL NORMALIZED RATIO - A GUIDE TO UNDERSTANDING AND CORRECTING ITS PROBLEMS
    HIRSH, J
    POLLER, L
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (03) : 282 - 288